P. Joly, J. Roujeau, and J. Benichou, A Comparison of Two Regimens of Topical Corticosteroids in the Treatment of Patients with Bullous Pemphigoid: A Multicenter Randomized Study, Journal of Investigative Dermatology, vol.129, issue.7, pp.1681-1687, 2009.
DOI : 10.1038/jid.2008.412
URL : https://hal.archives-ouvertes.fr/hal-00396990

C. Feliciani, P. Joly, and M. Jonkman, Management of bullous pemphigoid: the European Dermatology Forum consensus in collaboration with the European Academy of Dermatology and Venereology, British Journal of Dermatology, vol.138, issue.4, pp.867-877, 2015.
DOI : 10.1016/j.annder.2011.01.009

S. Bastuji-garin, P. Joly, and C. Picard-dahan, Drugs associated with bullous pemphigoid. A case-control study, Archives of Dermatology, vol.132, issue.3, pp.272-276, 1996.
DOI : 10.1001/archderm.132.3.272

B. En-e, J. Moulis, G. Bennani, and I. , Bullous pemphigoid and dipeptidyl peptidase IV inhibitors: a case-noncase study in the French Pharmacovigilance Database, Br J Dermatol, vol.175, issue.2, pp.296-301, 2016.

M. Garc-ia, M. Aranburu, and I. Palacios-zabalza, Dipeptidyl peptidase-IV inhibitors induced bullous pemphigoid: a case report and analysis of cases reported in the European pharmacovigilance database, Journal of Clinical Pharmacy and Therapeutics, vol.26, issue.3, pp.368-370, 2016.
DOI : 10.1111/j.1468-3083.2011.04062.x

H. Keseroglu, G. Tas¸-tas¸-aygar, and M. , A case of bullous pemphigoid ??nduced by vildagliptin, Cutaneous and Ocular Toxicology, vol.36, issue.2, pp.1-2, 2016.
DOI : 10.1111/jdv.12366

R. Haber, A. Fayad, and F. Stephan, Bullous Pemphigoid Associated With Linagliptin Treatment, JAMA Dermatology, vol.152, issue.2, pp.224-226, 2016.
DOI : 10.1001/jamadermatol.2015.2939

E. Pasmatzi, A. Monastirli, and J. Habeos, Dipeptidyl Peptidase-4 Inhibitors Cause Bullous Pemphigoid in Diabetic Patients: Report of Two Cases, Diabetes Care, vol.34, issue.8, p.133, 2011.
DOI : 10.2337/dc11-0804

K. Skandalis, M. Spirova, and G. Gaitanis, Drug-induced bullous pemphigoid in diabetes mellitus patients receiving dipeptidyl peptidase-IV inhibitors plus metformin, Journal of the European Academy of Dermatology and Venereology, vol.161, issue.2, pp.249-253, 2012.
DOI : 10.1111/j.1365-2133.2009.09266.x

I. Aouidad, C. Fite, and E. Marinho, A Case Report of Bullous Pemphigoid Induced by Dipeptidyl Peptidase-4 Inhibitors, JAMA Dermatology, vol.149, issue.2, pp.243-245, 2013.
DOI : 10.1001/jamadermatol.2013.1073

A. Attaway, T. Mersfelder, S. Vaishnav, and J. Baker, Bullous pemphigoid associated with dipeptidyl peptidase IV inhibitors. A case report and review of literature., Journal of Dermatological Case Reports, vol.8, issue.1, pp.24-28, 2014.
DOI : 10.3315/jdcr.2014.1166
URL : http://europepmc.org/articles/pmc3989094?pdf=render

B. En-e, J. Jacobsoone, A. Coupe, and P. , Bullous pemphigoid induced by vildagliptin: a report of three cases, Fundam Clin Pharmacol, vol.29, pp.112-114, 2015.

F. Mendonça, F. Mart-in-gutierrez, J. Mart-in, and F. Camacho-martinez, Three Cases of Bullous Pemphigoid Associated with Dipeptidyl Peptidase-4 Inhibitors - One due to Linagliptin, Dermatology, vol.232, issue.2, pp.249-253, 2016.
DOI : 10.1159/000443330

P. Joly, P. Courville, and C. Lok, Clinical Criteria for the Diagnosis of Bullous Pemphigoid: A Reevaluation according to Immunoblot Analysis of Patient Sera, Dermatology, vol.208, issue.1, pp.16-20, 2004.
DOI : 10.1159/000075040

P. Joly, J. Roujeau, and J. Benichou, A Comparison of Oral and Topical Corticosteroids in Patients with Bullous Pemphigoid, New England Journal of Medicine, vol.346, issue.5, pp.321-327, 2002.
DOI : 10.1056/NEJMoa011592

K. Izumi, W. Nishie, and Y. Mai, Autoantibody Profile Differentiates between Inflammatory and Noninflammatory Bullous Pemphigoid, Journal of Investigative Dermatology, vol.136, issue.11, pp.2201-2210, 2016.
DOI : 10.1016/j.jid.2016.06.622

U. Forssmann, C. Stoetzer, and M. Stephan, Inhibition of CD26/Dipeptidyl Peptidase IV Enhances CCL11/Eotaxin-Mediated Recruitment of Eosinophils In Vivo, The Journal of Immunology, vol.181, issue.2
DOI : 10.4049/jimmunol.181.2.1120

A. Thielitz, R. Vetter, and B. Schultze, Inhibitors of Dipeptidyl Peptidase IV-Like Activity Mediate Antifibrotic Effects in Normal and Keloid-Derived Skin Fibroblasts, Journal of Investigative Dermatology, vol.128, issue.4, pp.855-866, 2008.
DOI : 10.1038/sj.jid.5701104

P. Hoffmann, P. Bentley, and P. Sahota, Vascular Origin of Vildagliptin-induced Skin Effects in Cynomolgus Monkeys, Toxicologic Pathology, vol.15, issue.4, pp.684-695, 2014.
DOI : 10.1172/JCI0215595